BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guariento S, Tonelli M, Espinoza S, Gerasimov AS, Gainetdinov RR, Cichero E. Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists. European Journal of Medicinal Chemistry 2018;146:171-84. [DOI: 10.1016/j.ejmech.2018.01.059] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liao S, Pino MJ Jr, Deleon C, Lindner-Jackson M, Wu C. Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB. Life Sci 2022;:120553. [PMID: 35452636 DOI: 10.1016/j.lfs.2022.120553] [Reference Citation Analysis]
2 Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L. Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia. ACS Med Chem Lett 2022;13:92-8. [PMID: 35047111 DOI: 10.1021/acsmedchemlett.1c00527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sabbadini R, Pesce E, Parodi A, Mustorgi E, Bruzzone S, Pedemonte N, Casale M, Millo E, Cichero E. Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR Modulators. Pharmaceuticals (Basel) 2021;14:1296. [PMID: 34959696 DOI: 10.3390/ph14121296] [Reference Citation Analysis]
4 Gainetdinov RR, Hoener MC, Berry MD. Trace Amines and Their Receptors.Pharmacol Rev. 2018;70:549-620. [PMID: 29941461 DOI: 10.1124/pr.117.015305] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 24.5] [Reference Citation Analysis]
5 Akella M, Malla R. Molecular modeling and in vitro study on pyrocatechol as potential pharmacophore of CD151 inhibitor. J Mol Graph Model 2020;100:107681. [PMID: 32738620 DOI: 10.1016/j.jmgm.2020.107681] [Reference Citation Analysis]
6 Alnefeesi Y, Tamura JK, Lui LMW, Jawad MY, Ceban F, Ling S, Nasri F, Rosenblat JD, McIntyre RS. Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review. Neurosci Biobehav Rev 2021;131:192-210. [PMID: 34537265 DOI: 10.1016/j.neubiorev.2021.09.020] [Reference Citation Analysis]
7 Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F. The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity. Pharmaceuticals (Basel) 2021;14:720. [PMID: 34451817 DOI: 10.3390/ph14080720] [Reference Citation Analysis]
8 Francesconi V, Cichero E, Kanov EV, Laurini E, Pricl S, Gainetdinov RR, Tonelli M. Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Pharmaceuticals (Basel) 2020;13:E391. [PMID: 33202687 DOI: 10.3390/ph13110391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
9 Mishra A, Dey S. Molecular Docking Studies of a Cyclic Octapeptide-Cyclosaplin from Sandalwood. Biomolecules 2019;9:E740. [PMID: 31731771 DOI: 10.3390/biom9110740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Zeb A, Kim D, Alam SI, Son M, Kumar R, Rampogu S, Parameswaran S, Shelake RM, Rana RM, Parate S, Kim JY, Lee KW. Computational Simulations Identify Pyrrolidine-2,3-Dione Derivatives as Novel Inhibitors of Cdk5/p25 Complex to Attenuate Alzheimer's Pathology. J Clin Med 2019;8:E746. [PMID: 31137734 DOI: 10.3390/jcm8050746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Yamamoto K, Tsuda Y, Kuriyama M, Demizu Y, Onomura O. Copper-Catalyzed Enantioselective Synthesis of Oxazolines from Aminotriols via Asymmetric Desymmetrization. Chem Asian J 2020;15:840-4. [PMID: 32030893 DOI: 10.1002/asia.201901742] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Aarjane M, Slassi S, Ghaleb A, Tazi B, Amine A. Synthesis, biological evaluation, molecular docking and in silico ADMET screening studies of novel isoxazoline derivatives from acridone. Arabian Journal of Chemistry 2021;14:103057. [DOI: 10.1016/j.arabjc.2021.103057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Tomorowicz Ł, Sławiński J, Żołnowska B, Szafrański K, Kawiak A. Synthesis, Antitumor Evaluation, Molecular Modeling and Quantitative Structure-Activity Relationship (QSAR) of Novel 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-4-chloro-5-methyl-N-(1H-benzo[d]imidazol-2(3H)-ylidene)Benzenesulfonamides. Int J Mol Sci 2020;21:E2924. [PMID: 32331219 DOI: 10.3390/ijms21082924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Khairullina VR, Gimadieva AR, Gerchikov AY, Mustafin AG, Zarudii FS. Quantitative structure-activity relationship of the thymidylate synthase inhibitors of Mus musculus in the series of quinazolin-4-one and quinazolin-4-imine derivatives. J Mol Graph Model 2018;85:198-211. [PMID: 30227365 DOI: 10.1016/j.jmgm.2018.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 de Angelo RM, Almeida MO, de Paula H, Honorio KM. Studies on the Dual Activity of EGFR and HER-2 Inhibitors Using Structure-Based Drug Design Techniques. Int J Mol Sci 2018;19:E3728. [PMID: 30477154 DOI: 10.3390/ijms19123728] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
16 Righetti G, Casale M, Liessi N, Tasso B, Salis A, Tonelli M, Millo E, Pedemonte N, Fossa P, Cichero E. Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors. Int J Mol Sci 2020;21:E8084. [PMID: 33138251 DOI: 10.3390/ijms21218084] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Farfán-García ED, Márquez-Gómez R, Barrón-González M, Pérez-Capistran T, Rosales-Hernández MC, Pinto-Almazán R, Soriano-Ursúa MA. Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer's Disease. Curr Alzheimer Res 2019;16:871-94. [PMID: 30963972 DOI: 10.2174/1570159X17666190409144558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Tonelli M, Cichero E. Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present). Expert Opinion on Therapeutic Patents 2020;30:137-45. [DOI: 10.1080/13543776.2020.1708900] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
19 Kathuria D, Raul AD, Wanjari P, Bharatam PV. Biguanides: Species with versatile therapeutic applications. Eur J Med Chem 2021;219:113378. [PMID: 33857729 DOI: 10.1016/j.ejmech.2021.113378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]